基于氨基酸的碳点的合成:对口腔癌细胞的影响
So-Young Park1, Wooil Kim2, Ae-Ri Pyo3
1Department of Pediatric Dentistry, School of Dentistry, Pusan National University, Yangsan, Korea.
American journal of dentistry
|February 25, 2025
概括
基于氨基酸的碳点 (CD) 在与过氧化和激光照射相结合时,有效消除了近74%的体外癌细胞. 这项研究突出了这些碳点对未来癌症治疗的潜力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 光动力学疗法 光动力学疗法
背景情况:
- 碳点 (CD) 是一种新兴的纳米材料,具有多种应用.
- 氨基酸修改增强了CD的生物相容性和功能.
- 光动力疗法 (PDT) 使用光敏剂产生活性氧物种 (ROS) 用于癌症治疗.
研究的目的:
- 合成和评估基于氨基酸的碳点 (CDs) 对于它们在消除癌细胞中的有效性.
- 在特定条件下,研究由CDs诱导的癌细胞死亡机制.
主要方法:
- 使用氨酸合成CD,并用金属和光敏感剂修改.
- 在癌症和正常细胞上进行了体外细胞活力测试.
- 使用甲蓝,实时氧探测器和RNO-ID测定分别量化了ROS生产,氧生成和单点氧生成.
主要成果:
- 基于氨基酸的CDs (fn-Cei-Ce6) 显著降低了癌细胞活力,在20ppm时大约降至26%.
- 在H2O2和激光照射下观察到增强的ROS生产,氧气生成 (~1.2 mg/L) 和单点氧气生成.
- 高吸收率差异和RNO-ID测定中的下降证实了高效的ROS生成.
结论:
- 基于氨基酸的CD显示了显著的体外癌细胞消除 (近74%的减少).
- 观察到的ROS和单点氧生成机制有助于观察到的细胞毒性.
- 这些发现表明fn-Cei-Ce6在治疗口腔瘤方面的潜在临床应用.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...


